Finite-element model of interaction between fungal polysaccharide and monoclonal antibody in the capsule of Cryptococcus neoformans

Vineet Rakesh, Andrew D. Schweitzer, Oscar Zaragoza, Ruth Bryan, Kevin Wong, Ashim Datta, Arturo Casadevall, Ekaterina Dadachova

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Many microorganisms such as bacteria and fungi possess so-called capsules made of polysaccharides which protect these microorganisms from environmental insults and host immune defenses. The polysaccharide capsule of Cryptococcus neoformans, a human pathogenic yeast, is capable of self-assembly, composed mostly of glucuronoxylomannan (GXM), a polysaccharide with a molecular weight of approximately 2 000 000, and has several layers with different densities. The objective of this study was to model pore-hindered diffusion and binding of the GXM-specific antibody within the C. neoformans capsule. Using the finite-element method (FEM), we created a model which represents the in vivo binding of a GXM-specific antibody to a C. neoformans cell taking into account the intravenous infusion time of antibody, antibody diffusion through capsular pores, and Michaelis-Menten kinetics of antibody binding to capsular GXM. The model predicted rapid diffusion of antibody to all regions of the capsule where the pore size was greater than the Stokes diameter of the antibody. Binding occurred primarily at intermediate regions of the capsule. The GXM concentration in each capsular region was the principal determinant of the steady-state antibody-GXM complex concentration, while the forward binding rate constant influenced the rate of complex formation in each region. The concentration profiles predicted by the model closely matched experimental immunofluorescence data. Inclusion of different antibody isotypes (IgG, IgA, and IgM) into the modeling algorithm resulted in similar complex formation in the outer capsular regions, but different depths of binding at the inner regions. These results have implications for the development of new antibody-based therapies.

Original languageEnglish (US)
Pages (from-to)8514-8522
Number of pages9
JournalJournal of Physical Chemistry B
Volume112
Issue number29
DOIs
StatePublished - Jul 24 2008

Fingerprint

Fungal Polysaccharides
Monoclonal antibodies
polysaccharides
capsules
Polysaccharides
antibodies
Antibodies
Capsules
Monoclonal Antibodies
interactions
microorganisms
porosity
Microorganisms
fungi
yeast
Fungi
determinants
Yeast
Self assembly
Immunoglobulin A

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry

Cite this

Finite-element model of interaction between fungal polysaccharide and monoclonal antibody in the capsule of Cryptococcus neoformans. / Rakesh, Vineet; Schweitzer, Andrew D.; Zaragoza, Oscar; Bryan, Ruth; Wong, Kevin; Datta, Ashim; Casadevall, Arturo; Dadachova, Ekaterina.

In: Journal of Physical Chemistry B, Vol. 112, No. 29, 24.07.2008, p. 8514-8522.

Research output: Contribution to journalArticle

Rakesh, V, Schweitzer, AD, Zaragoza, O, Bryan, R, Wong, K, Datta, A, Casadevall, A & Dadachova, E 2008, 'Finite-element model of interaction between fungal polysaccharide and monoclonal antibody in the capsule of Cryptococcus neoformans', Journal of Physical Chemistry B, vol. 112, no. 29, pp. 8514-8522. https://doi.org/10.1021/jp8018205
Rakesh, Vineet ; Schweitzer, Andrew D. ; Zaragoza, Oscar ; Bryan, Ruth ; Wong, Kevin ; Datta, Ashim ; Casadevall, Arturo ; Dadachova, Ekaterina. / Finite-element model of interaction between fungal polysaccharide and monoclonal antibody in the capsule of Cryptococcus neoformans. In: Journal of Physical Chemistry B. 2008 ; Vol. 112, No. 29. pp. 8514-8522.
@article{e4e6d1df404e4b1388ac483364ae4f03,
title = "Finite-element model of interaction between fungal polysaccharide and monoclonal antibody in the capsule of Cryptococcus neoformans",
abstract = "Many microorganisms such as bacteria and fungi possess so-called capsules made of polysaccharides which protect these microorganisms from environmental insults and host immune defenses. The polysaccharide capsule of Cryptococcus neoformans, a human pathogenic yeast, is capable of self-assembly, composed mostly of glucuronoxylomannan (GXM), a polysaccharide with a molecular weight of approximately 2 000 000, and has several layers with different densities. The objective of this study was to model pore-hindered diffusion and binding of the GXM-specific antibody within the C. neoformans capsule. Using the finite-element method (FEM), we created a model which represents the in vivo binding of a GXM-specific antibody to a C. neoformans cell taking into account the intravenous infusion time of antibody, antibody diffusion through capsular pores, and Michaelis-Menten kinetics of antibody binding to capsular GXM. The model predicted rapid diffusion of antibody to all regions of the capsule where the pore size was greater than the Stokes diameter of the antibody. Binding occurred primarily at intermediate regions of the capsule. The GXM concentration in each capsular region was the principal determinant of the steady-state antibody-GXM complex concentration, while the forward binding rate constant influenced the rate of complex formation in each region. The concentration profiles predicted by the model closely matched experimental immunofluorescence data. Inclusion of different antibody isotypes (IgG, IgA, and IgM) into the modeling algorithm resulted in similar complex formation in the outer capsular regions, but different depths of binding at the inner regions. These results have implications for the development of new antibody-based therapies.",
author = "Vineet Rakesh and Schweitzer, {Andrew D.} and Oscar Zaragoza and Ruth Bryan and Kevin Wong and Ashim Datta and Arturo Casadevall and Ekaterina Dadachova",
year = "2008",
month = "7",
day = "24",
doi = "10.1021/jp8018205",
language = "English (US)",
volume = "112",
pages = "8514--8522",
journal = "Journal of Physical Chemistry B Materials",
issn = "1520-6106",
publisher = "American Chemical Society",
number = "29",

}

TY - JOUR

T1 - Finite-element model of interaction between fungal polysaccharide and monoclonal antibody in the capsule of Cryptococcus neoformans

AU - Rakesh, Vineet

AU - Schweitzer, Andrew D.

AU - Zaragoza, Oscar

AU - Bryan, Ruth

AU - Wong, Kevin

AU - Datta, Ashim

AU - Casadevall, Arturo

AU - Dadachova, Ekaterina

PY - 2008/7/24

Y1 - 2008/7/24

N2 - Many microorganisms such as bacteria and fungi possess so-called capsules made of polysaccharides which protect these microorganisms from environmental insults and host immune defenses. The polysaccharide capsule of Cryptococcus neoformans, a human pathogenic yeast, is capable of self-assembly, composed mostly of glucuronoxylomannan (GXM), a polysaccharide with a molecular weight of approximately 2 000 000, and has several layers with different densities. The objective of this study was to model pore-hindered diffusion and binding of the GXM-specific antibody within the C. neoformans capsule. Using the finite-element method (FEM), we created a model which represents the in vivo binding of a GXM-specific antibody to a C. neoformans cell taking into account the intravenous infusion time of antibody, antibody diffusion through capsular pores, and Michaelis-Menten kinetics of antibody binding to capsular GXM. The model predicted rapid diffusion of antibody to all regions of the capsule where the pore size was greater than the Stokes diameter of the antibody. Binding occurred primarily at intermediate regions of the capsule. The GXM concentration in each capsular region was the principal determinant of the steady-state antibody-GXM complex concentration, while the forward binding rate constant influenced the rate of complex formation in each region. The concentration profiles predicted by the model closely matched experimental immunofluorescence data. Inclusion of different antibody isotypes (IgG, IgA, and IgM) into the modeling algorithm resulted in similar complex formation in the outer capsular regions, but different depths of binding at the inner regions. These results have implications for the development of new antibody-based therapies.

AB - Many microorganisms such as bacteria and fungi possess so-called capsules made of polysaccharides which protect these microorganisms from environmental insults and host immune defenses. The polysaccharide capsule of Cryptococcus neoformans, a human pathogenic yeast, is capable of self-assembly, composed mostly of glucuronoxylomannan (GXM), a polysaccharide with a molecular weight of approximately 2 000 000, and has several layers with different densities. The objective of this study was to model pore-hindered diffusion and binding of the GXM-specific antibody within the C. neoformans capsule. Using the finite-element method (FEM), we created a model which represents the in vivo binding of a GXM-specific antibody to a C. neoformans cell taking into account the intravenous infusion time of antibody, antibody diffusion through capsular pores, and Michaelis-Menten kinetics of antibody binding to capsular GXM. The model predicted rapid diffusion of antibody to all regions of the capsule where the pore size was greater than the Stokes diameter of the antibody. Binding occurred primarily at intermediate regions of the capsule. The GXM concentration in each capsular region was the principal determinant of the steady-state antibody-GXM complex concentration, while the forward binding rate constant influenced the rate of complex formation in each region. The concentration profiles predicted by the model closely matched experimental immunofluorescence data. Inclusion of different antibody isotypes (IgG, IgA, and IgM) into the modeling algorithm resulted in similar complex formation in the outer capsular regions, but different depths of binding at the inner regions. These results have implications for the development of new antibody-based therapies.

UR - http://www.scopus.com/inward/record.url?scp=49149086327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49149086327&partnerID=8YFLogxK

U2 - 10.1021/jp8018205

DO - 10.1021/jp8018205

M3 - Article

C2 - 18588334

AN - SCOPUS:49149086327

VL - 112

SP - 8514

EP - 8522

JO - Journal of Physical Chemistry B Materials

JF - Journal of Physical Chemistry B Materials

SN - 1520-6106

IS - 29

ER -